Article
Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jul 2013
Sanford Dominic E, Belt Brian A, Panni Roheena Z, Mayer Allese, Deshpande Anjali D, Carpenter Danielle, Mitchem Jonathan B, Plambeck-Suess Stacey M, Worley Lori A, Goetz Brian D, Wang-Gillam Andrea, Eberlein Timothy J, Denardo David G, Goedegebuure Simon Peter, Linehan David C
Abstract excerpt
PURPOSE: To determine the role of the CCL2/CCR2 axis and inflammatory monocytes (CCR2(+)/CD14(+)) as immunotherapeutic targets in the treatment of pancreatic cancer. EXPERIMENTAL DESIGN: Survival analysis was conducted to determine if the prevalence of preoperative blood monocytes correlates with survival in patients with pancreatic cancer following tumor resection. Inflammatory monocyte prevalence in the blood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
